FindTrial
Sign In

Nasal Glucagon

DRUG9 trials

Sponsors

Eli Lilly and Company

Conditions

Common ColdDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Drug-Specific AntibodiesHealthyHypoglycemia

Phase 1

A Study of Nasal Glucagon in Participants With a Common Cold
CompletedNCT02778100
Eli Lilly and CompanyCommon Cold
Start: 2013-03-31End: 2013-04-30Updated: 2019-09-18
A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults
CompletedNCT02778113
Eli Lilly and CompanyHealthy
Start: 2011-10-31End: 2011-11-30Updated: 2019-09-19
A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes
CompletedNCT02806973
Eli Lilly and CompanyDiabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Start: 2015-01-31End: 2015-04-30Updated: 2019-10-14
A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes
TerminatedNCT02806960
Eli Lilly and CompanyDiabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Start: 2014-06-30End: 2014-08-31Updated: 2019-12-13
A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus
CompletedNCT03339453
Eli Lilly and CompanyDiabetes Mellitus, Type 1, Hypoglycemia
Start: 2017-11-10End: 2018-01-13Updated: 2019-09-23

Phase 2

Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes
CompletedNCT01997411
Eli Lilly and CompanyDiabetes Mellitus, Type 1
Start: 2013-11-30End: 2015-01-31Updated: 2018-08-29

Phase 3

Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults
CompletedNCT01994746
Eli Lilly and CompanyDiabetes Mellitus, Type 1
Start: 2013-11-30End: 2015-01-31Updated: 2019-09-23
Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia
CompletedNCT02171130
Eli Lilly and CompanyDiabetes Mellitus, Drug-Specific Antibodies, Hypoglycemia
Start: 2014-05-31End: 2015-08-31Updated: 2019-10-15
Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents
CompletedNCT02402933
Eli Lilly and CompanyDiabetes Mellitus, Hypoglycemia
Start: 2015-03-31End: 2015-08-31Updated: 2019-09-23

Related Papers

Nasal Glucagon Reverses Insulin-induced Hypoglycemia With Less Rebound Hyperglycemia: Pooled Analysis of Clinical Trials
Journal of the Endocrine Society2024-02-192 citations
Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study
Diabetes Therapy2020-06-0831 citations